Activation of peroxisome proliferator-activated receptor-γ and retinoid X receptor inhibits aromatase transcription via nuclear factor-κB

Wu Qiang Fan, Toshihiko Yanase, Hidetaka Morinaga, Yi Ming Mu, Masatoshi Nomura, Taijiro Okabe, Kiminobu Goto, Nobuhiro Harada, Hajime Nawata

Research output: Contribution to journalArticle

80 Citations (Scopus)

Abstract

Our previous studies demonstrated that a peroxisome proliferator-activated receptor (PPAR)-γligand, troglitazone (TGZ), and/or a retinoid X receptor (RXR) ligand, LG1G0268 (LG), decreased the aromatase activity in both cultured human ovarian granulosa cells and human granulosa-like tumor KGN cells. In the present study, we further found that a combined treatment of TGZ+LG decreased aromatase promoter II (ArPII) activity in both ovarian KGN cells and fibroblast NIH-3T3 cells in a PPARγ-dependent manner. Furthermore, the inhibition of both aromatase activity and the transcription of ArPII by TGZ+LG was completely eliminated when nuclear factor-κB (NF-κB) signaling was blocked by specific inhibitors, suggesting NF-κB, which is endogenously expressed in both fibroblast and granulosa cells, might be a mediator of this inhibition. Interestingly, activation of NF-κB by either forced expression of the p65 subunit or NF-κB-inducing kinase up-regulated ArPII activity. Positive regulation of aromatase by endogenous NF-κB was also suggested by the fact that NF-κB-specific inhibitors suppress basal activity of the aromatase gene. A concomitant formation of high-order complex between NF-κB p65 and ArPII was also observed by chromatin immunoprecipitation assay. Although activation of PPARγ and RXR affected endogenous expression levels of neither inhibitory κBα nor p65, it impaired the interaction between NF-κB and ArPII and the p65 based transcription as well. Altogether, these results indicate that activation of a nuclear receptor system, constituted by PPARγ and RXR, down-regulates aromatase expression through the suppression of NF-κB-dependent aromatase activation and thus provide a new insight in the mechanism of regulation of the aromatase gene.

Original languageEnglish
Pages (from-to)85-92
Number of pages8
JournalEndocrinology
Volume146
Issue number1
DOIs
Publication statusPublished - Jan 1 2005

Fingerprint

Retinoid X Receptors
Peroxisome Proliferator-Activated Receptors
Aromatase
troglitazone
Granulosa Cells
Fibroblasts
Ligands
NIH 3T3 Cells
Chromatin Immunoprecipitation
Cytoplasmic and Nuclear Receptors
Genes

All Science Journal Classification (ASJC) codes

  • Endocrinology

Cite this

Activation of peroxisome proliferator-activated receptor-γ and retinoid X receptor inhibits aromatase transcription via nuclear factor-κB. / Fan, Wu Qiang; Yanase, Toshihiko; Morinaga, Hidetaka; Mu, Yi Ming; Nomura, Masatoshi; Okabe, Taijiro; Goto, Kiminobu; Harada, Nobuhiro; Nawata, Hajime.

In: Endocrinology, Vol. 146, No. 1, 01.01.2005, p. 85-92.

Research output: Contribution to journalArticle

Fan, WQ, Yanase, T, Morinaga, H, Mu, YM, Nomura, M, Okabe, T, Goto, K, Harada, N & Nawata, H 2005, 'Activation of peroxisome proliferator-activated receptor-γ and retinoid X receptor inhibits aromatase transcription via nuclear factor-κB', Endocrinology, vol. 146, no. 1, pp. 85-92. https://doi.org/10.1210/en.2004-1046
Fan, Wu Qiang ; Yanase, Toshihiko ; Morinaga, Hidetaka ; Mu, Yi Ming ; Nomura, Masatoshi ; Okabe, Taijiro ; Goto, Kiminobu ; Harada, Nobuhiro ; Nawata, Hajime. / Activation of peroxisome proliferator-activated receptor-γ and retinoid X receptor inhibits aromatase transcription via nuclear factor-κB. In: Endocrinology. 2005 ; Vol. 146, No. 1. pp. 85-92.
@article{e201df1534cc45989a38f1acc27dcb81,
title = "Activation of peroxisome proliferator-activated receptor-γ and retinoid X receptor inhibits aromatase transcription via nuclear factor-κB",
abstract = "Our previous studies demonstrated that a peroxisome proliferator-activated receptor (PPAR)-γligand, troglitazone (TGZ), and/or a retinoid X receptor (RXR) ligand, LG1G0268 (LG), decreased the aromatase activity in both cultured human ovarian granulosa cells and human granulosa-like tumor KGN cells. In the present study, we further found that a combined treatment of TGZ+LG decreased aromatase promoter II (ArPII) activity in both ovarian KGN cells and fibroblast NIH-3T3 cells in a PPARγ-dependent manner. Furthermore, the inhibition of both aromatase activity and the transcription of ArPII by TGZ+LG was completely eliminated when nuclear factor-κB (NF-κB) signaling was blocked by specific inhibitors, suggesting NF-κB, which is endogenously expressed in both fibroblast and granulosa cells, might be a mediator of this inhibition. Interestingly, activation of NF-κB by either forced expression of the p65 subunit or NF-κB-inducing kinase up-regulated ArPII activity. Positive regulation of aromatase by endogenous NF-κB was also suggested by the fact that NF-κB-specific inhibitors suppress basal activity of the aromatase gene. A concomitant formation of high-order complex between NF-κB p65 and ArPII was also observed by chromatin immunoprecipitation assay. Although activation of PPARγ and RXR affected endogenous expression levels of neither inhibitory κBα nor p65, it impaired the interaction between NF-κB and ArPII and the p65 based transcription as well. Altogether, these results indicate that activation of a nuclear receptor system, constituted by PPARγ and RXR, down-regulates aromatase expression through the suppression of NF-κB-dependent aromatase activation and thus provide a new insight in the mechanism of regulation of the aromatase gene.",
author = "Fan, {Wu Qiang} and Toshihiko Yanase and Hidetaka Morinaga and Mu, {Yi Ming} and Masatoshi Nomura and Taijiro Okabe and Kiminobu Goto and Nobuhiro Harada and Hajime Nawata",
year = "2005",
month = "1",
day = "1",
doi = "10.1210/en.2004-1046",
language = "English",
volume = "146",
pages = "85--92",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "1",

}

TY - JOUR

T1 - Activation of peroxisome proliferator-activated receptor-γ and retinoid X receptor inhibits aromatase transcription via nuclear factor-κB

AU - Fan, Wu Qiang

AU - Yanase, Toshihiko

AU - Morinaga, Hidetaka

AU - Mu, Yi Ming

AU - Nomura, Masatoshi

AU - Okabe, Taijiro

AU - Goto, Kiminobu

AU - Harada, Nobuhiro

AU - Nawata, Hajime

PY - 2005/1/1

Y1 - 2005/1/1

N2 - Our previous studies demonstrated that a peroxisome proliferator-activated receptor (PPAR)-γligand, troglitazone (TGZ), and/or a retinoid X receptor (RXR) ligand, LG1G0268 (LG), decreased the aromatase activity in both cultured human ovarian granulosa cells and human granulosa-like tumor KGN cells. In the present study, we further found that a combined treatment of TGZ+LG decreased aromatase promoter II (ArPII) activity in both ovarian KGN cells and fibroblast NIH-3T3 cells in a PPARγ-dependent manner. Furthermore, the inhibition of both aromatase activity and the transcription of ArPII by TGZ+LG was completely eliminated when nuclear factor-κB (NF-κB) signaling was blocked by specific inhibitors, suggesting NF-κB, which is endogenously expressed in both fibroblast and granulosa cells, might be a mediator of this inhibition. Interestingly, activation of NF-κB by either forced expression of the p65 subunit or NF-κB-inducing kinase up-regulated ArPII activity. Positive regulation of aromatase by endogenous NF-κB was also suggested by the fact that NF-κB-specific inhibitors suppress basal activity of the aromatase gene. A concomitant formation of high-order complex between NF-κB p65 and ArPII was also observed by chromatin immunoprecipitation assay. Although activation of PPARγ and RXR affected endogenous expression levels of neither inhibitory κBα nor p65, it impaired the interaction between NF-κB and ArPII and the p65 based transcription as well. Altogether, these results indicate that activation of a nuclear receptor system, constituted by PPARγ and RXR, down-regulates aromatase expression through the suppression of NF-κB-dependent aromatase activation and thus provide a new insight in the mechanism of regulation of the aromatase gene.

AB - Our previous studies demonstrated that a peroxisome proliferator-activated receptor (PPAR)-γligand, troglitazone (TGZ), and/or a retinoid X receptor (RXR) ligand, LG1G0268 (LG), decreased the aromatase activity in both cultured human ovarian granulosa cells and human granulosa-like tumor KGN cells. In the present study, we further found that a combined treatment of TGZ+LG decreased aromatase promoter II (ArPII) activity in both ovarian KGN cells and fibroblast NIH-3T3 cells in a PPARγ-dependent manner. Furthermore, the inhibition of both aromatase activity and the transcription of ArPII by TGZ+LG was completely eliminated when nuclear factor-κB (NF-κB) signaling was blocked by specific inhibitors, suggesting NF-κB, which is endogenously expressed in both fibroblast and granulosa cells, might be a mediator of this inhibition. Interestingly, activation of NF-κB by either forced expression of the p65 subunit or NF-κB-inducing kinase up-regulated ArPII activity. Positive regulation of aromatase by endogenous NF-κB was also suggested by the fact that NF-κB-specific inhibitors suppress basal activity of the aromatase gene. A concomitant formation of high-order complex between NF-κB p65 and ArPII was also observed by chromatin immunoprecipitation assay. Although activation of PPARγ and RXR affected endogenous expression levels of neither inhibitory κBα nor p65, it impaired the interaction between NF-κB and ArPII and the p65 based transcription as well. Altogether, these results indicate that activation of a nuclear receptor system, constituted by PPARγ and RXR, down-regulates aromatase expression through the suppression of NF-κB-dependent aromatase activation and thus provide a new insight in the mechanism of regulation of the aromatase gene.

UR - http://www.scopus.com/inward/record.url?scp=11144236524&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=11144236524&partnerID=8YFLogxK

U2 - 10.1210/en.2004-1046

DO - 10.1210/en.2004-1046

M3 - Article

C2 - 15459115

AN - SCOPUS:11144236524

VL - 146

SP - 85

EP - 92

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 1

ER -